tweetindex
ID

Springer Health+ IME

@SpringerIME · Global · joined 14 Mar 2016

Springer Health+ IME, providing independent medical education in Neurology, Diabetes, Oncology, Rare Diseases, Endocrinology, and Paediatrics.

20 483Followers
2 762Following
1 987Posts total
5.6KViews on collected posts

Postingan terbaru

Candidate selection and surgical considerations for presbyopia-correcting intraocular lenses: Start learning in these free, CME-accredited patient case modules, developed by Dr. Rahul Tonk and Dr. Caroline Watson: https://t.co/mgizp3bVu3 https://t.co/wiSJ0XmC9q
GIF
846 views · 1 likes · 1 reposts · 0 replies Open on X →
Help shape the discussion at #ESCCongress 2026 by sharing your experience of managing patients with heart failure and kidney impairment. Which unmet need in HF with kidney impairment management are you most hopeful new evidence will address? 2.4K views · 1 likes · 0 reposts · 0 replies Open on X →
Unpick regional disparities and patient perspectives on systemic lupus erythematosus in this free, CME-accredited video series, led by Prof. Martin Aringer and international experts in lupus care: https://t.co/iPorCybzGd https://t.co/H6mr5MCfa9
GIF
1K views · 2 likes · 0 reposts · 0 replies Open on X →
Help shape the discussion at #ESCCongress 2026 by sharing your experience of managing patients with heart failure and kidney impairment. A patient's eGFR dips after starting an SGLT2 inhibitor. What's your first move? 629 views · 0 likes · 0 reposts · 1 replies Open on X →
Hear from Dr. Larisa J. Geskin and fellow clinical experts in our free, CME-accredited webcast, where they explore the evolving therapeutic landscape of the tumor microenvironment in mycosis fungoides–type cutaneous T-cell lymphoma: https://t.co/fJT3j6NZhE https://t.co/bwT0sSEH8D
GIF
673 views · 0 likes · 0 reposts · 0 replies Open on X →

Dibandingkan akun berukuran sama

5 postingan dari 90 hari terakhir, dibandingkan dengan rentang 10K–100K pengikut. jangkauan biasa untuk ukurannya, reaksi lebih lemah dari kebanyakan.

Median tayangan846akun ini924median untuk 10K–100K
Jangkauan, %4.13%akun ini3.62%median untuk 10K–100K
Interaksi, %0.16%akun ini1.52%median untuk 10K–100K
MetrikAkun iniMedian untuk 10K–100KRasio
Median tayangan per postingan8469240.92×
Jangkauan (tayangan ÷ pengikut)4.13%3.62%1.14×
Tingkat interaksi0.16%1.52%0.10×

Akun lain pada rentang ini →   Bandingkan dengan akun lain →   Bagaimana tolok ukur ini disusun →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

67326 Aug
62927 Aug
1K
2.4K28 Aug
8469 Sep

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.00%26 Aug
0.16%27 Aug
0.20%
0.04%28 Aug
0.24%9 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes66.7%4 in total
Reposts16.7%1 in total
Replies16.7%1 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Akun serupa